文献速递中医内科中医妇科中药与中成药合理使用

小刘汤通过诱导凋亡和抑制迁移抑制宫颈癌进展

Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration.
PubMed 文献 · J Ethnopharmacol · 2025-12-02

本研究基于中医气血理论探讨小刘汤(XLT)对宫颈癌的抗肿瘤作用与机制。在TC-1同种移植小鼠模型中,XLT抑制肿瘤生长64.93%(P<0.05)且未显著改变体重或一般行为;体外实验显示其抑制肿瘤细胞增殖与迁移,上调Caspase-3和Caspase-8,调控JAK/STAT与PI3K/AKT通路,转录组分析涉及EMT、细胞骨架、凋亡等。结论认为XLT通过诱导凋亡和抑制迁移发挥抗肿瘤作用,疗效与常规化疗相当但安全性更好,提示可用于宫颈癌临床转化。

要点

  • XLT在TC-1宫颈癌小鼠模型中抑制肿瘤生长64.93%(P<0.05),未显著改变体重或一般行为。
  • XLT体外抑制宫颈癌细胞增殖与迁移,上调Caspase-3和Caspase-8,调控JAK/STAT与PI3K/AKT通路。
  • 转录组分析提示XLT调节EMT、细胞骨架组织与凋亡,疗效与常规化疗相当但安全性更好。

核心结论

  • XLT通过诱导凋亡和抑制肿瘤细胞迁移发挥抗肿瘤作用,疗效与常规化疗相当但安全性更好,可能适合宫颈癌临床转化。

研究设计与样本

  • 采用TC-1宫颈癌同种移植小鼠模型评估XLT体内抗肿瘤疗效。
  • 体外采用转录组分析、Transwell迁移实验、 wound healing实验和CCK-8增殖实验探讨分子机制。

主要发现

  • XLT对肿瘤生长的抑制率为64.93%(P<0.05),治疗小鼠体重或一般行为无显著变化。
  • 细胞实验显示XLT显著抑制肿瘤细胞增殖和迁移。
  • 分子分析显示XLT上调Caspase-3和Caspase-8表达,同时调控JAK/STAT和PI3K/AKT信号通路。
  • 转录组分析识别出对上皮-间质转化(EMT)、细胞骨架组织、凋亡的调节,并验证了JAK/STAT和PI3K/AKT信号。

临床怎么用

  • XLT在宫颈癌模型中显示抗肿瘤疗效且安全性较好,提示可能作为宫颈癌治疗的候选方剂进行临床转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Xiao-Liu Tang (XLT), a formulation grounded in the Traditional Chinese medicine (TCM) theory of Qi-Blood, has shown promise in alleviating endometriosis-related symptoms through clinical observations, with emerging evidence supporting its anti-inflammatory and pro-apoptotic properties. Endometriosis shares oncogenic pathological hallmarks with gynecological malignancies-including evasion of apoptosis, and invasive potential. Building on TCM's multi-target therapeutic paradigm and the mechanistic parallels between these conditions, we hypothesize that XLT may exert broad anti-neoplastic effects. This study investigates its efficacy and molecular mechanisms in cervical cancer model. AIM OF THE STUDY: This study examined the anti-tumor effects and underlying mechanisms of XLT against cervical cancer. METHODS: The in vivo anti-tumor efficacy of XLT was assessed using a TC-1 cervical cancer allograft mouse model. To elucidate the molecular mechanisms, we performed in vitro investigations using transcriptomic analysis, transwell in vitro cell migration assays, wound healing assays, and CCK-8 proliferation assays. RESULTS: XLT demonstrated a 64.93 % inhibition of tumor growth (P < 0.05), without significant changes in body weight or general behavior in treated mice. Cell-based experiments showed significant suppression of tumor cell proliferation and migration. Molecular analysis showed XLT upregulated Caspase-3 and Caspase-8 expression while modulating the JAK/STAT and PI3K/AKT signaling pathways. Transcriptomic profiling identified regulation of epithelial-mesenchymal transition (EMT), cytoskeletal organization, apoptosis and verified JAK/STAT and PI3K/AKT signaling. CONCLUSION: XLT has anti-tumor effects by inducing apoptosis and inhibiting migration of tumor cells. The formula showed notable efficacy, comparable to conventional treatments (chemotherapy) but with greater safety, suggesting that it may be suitable for clinical translation in the treatment of cervical cancer.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Dang S, Tang X, Li Q, et al. Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration. J Ethnopharmacol. 2025. PMID: 41344524. doi:10.1016/j.jep.2025.120966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。